DarioHealth Corp. (DRIO) Earnings History
Profitable14 years of earnings data (2012–2025) · Positive TTM net income
Loading earnings history...
DarioHealth Corp. (DRIO) Earnings Overview
As of June 28, 2026, DarioHealth Corp. (DRIO) reported trailing twelve-month net income of $63M, reflecting +267.6% year-over-year growth. The company earned $1.26 per diluted share over the past four quarters, with a net profit margin of -186.6%.
Looking at the long-term picture, DRIO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2012.
DarioHealth Corp. maintains positive profitability with a gross margin of 56.6%, operating margin of -163.9%, and net margin of -186.6%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including TDOC (-$171M net income, -7.9% margin), OMCL ($20M net income, 0.2% margin), NVCR (-$173M net income, -20.8% margin), DRIO has room to improve margins relative to the peer group. Compare DRIO vs TDOC →
DRIO Earnings vs Peers
Earnings metrics vs comparable public companies
DRIO Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$42M | +2.4% | -$37M | $1.24 | -186.6% | -163.9% |
| 2024 | -$43M | +28.1% | -$58M | $-0.74 | -158.1% | -213.6% |
| 2023 | -$59M | +4.4% | -$56M | $-1.93 | -292.0% | -276.1% |
| 2022 | -$62M | +19.0% | -$57M | $-2.63 | -224.9% | -205.4% |
| 2021 | -$77M | -160.7% | -$76M | $-4.63 | -374.2% | -372.9% |
| 2020 | -$29M | -66.0% | -$30M | $-5.55 | -388.7% | -394.7% |
| 2019 | -$18M | +0.4% | -$18M | $-7.84 | -234.6% | -234.2% |
| 2018 | -$18M | -13.1% | -$18M | $-15.21 | -240.8% | -239.2% |
| 2017 | -$16M | -44.6% | -$14M | $-32.70 | -304.5% | -278.9% |
| 2016 | -$11M | -52.4% | -$11M | $-41.85 | -388.4% | -396.0% |
| 2015 | -$7M | +44.5% | -$8M | $-75.27 | -867.8% | -935.4% |
| 2014 | -$13M | +7.6% | -$11M | $-534.14 | -25249.0% | -22270.6% |
| 2013 | -$14M | -145.0% | -$14M | $-1369.35 | - | - |
| 2012 | -$6M | - | -$4M | $-512.72 | - | - |
Download Data
Export DRIO earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
DRIO — Frequently Asked Questions
Quick answers to the most common questions about buying DRIO stock.
What is DRIO earnings per share (EPS)?
DRIO trailing twelve-month (TTM) diluted EPS is $1.26, reflecting +267.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is DarioHealth Corp.'s net income?
DarioHealth Corp. (DRIO) trailing twelve-month net income is $63M as of 2025. Earnings grew +267.6% year-over-year.
Is DRIO profitable?
Yes, DRIO is profitable with a TTM net income of $63M and a net profit margin of -186.6%.
What is DRIO's earnings growth rate?
DRIO compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are DRIO's profit margins?
DarioHealth Corp. net profit margin is -186.6%, operating margin is -163.9%, and gross margin is +56.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is -59.6%.
Is DRIO growing earnings?
Yes, DRIO earnings are accelerating — EPS growth of +267.6% exceeds the 5-year CAGR of N/A. TTM net income reached $63M. Earnings momentum is strengthening.
What was DRIO's best earnings year?
DarioHealth Corp.'s highest annual net income on record is $-6M, achieved in fiscal year 2012. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were DRIO's earnings last quarter?
DRIO's most recent reported quarter was Q1 2026. Net income was $-8M with diluted EPS of $0.17. For a full breakdown of all quarters, see the quarterly earnings table on this page.